Scholars@Duke
Cynthia Ann Moylan

Cynthia Ann Moylan

Professor of Medicine
Medicine, Gastroenterology
cynthia.moylan@duke.edu
Duke Box 3256, 595 LaSalle GSRB 1, Durham, NC 27710
Duke South Clinic, 40 Medicine Circle, Room 0350, Durham, NC 27710

Scholarly Works - Conferences

Abstract 4903: Short chain per- and polyfluoroalkyl substances associate with elevated alanine aminotransferase: cross-sectional analysis results from the STRIVE cohort

Conference Cancer Research · April 21, 2025 AbstractBackground:Although long chain, high molecular weight per- and polyfluoroalkyl substances (PFAS) (≥8 and ≥6 carbons for carbox ... Full text Cite

S1856 How Parental Exercise Habits Influence Their Children's Liver Health

Conference American Journal of Gastroenterology · October 2024 Full text Cite

1986-LB: Feasibility and Acceptability of an Intervention to Improve Metabolic Liver Disease in Latino/a and Black Patients with Diabetes

Conference Diabetes · June 14, 2024 Patients with type 2 diabetes (T2D), and particularly those from historically marginalized racial/ethnic groups, are at high risk of poor outcomes from metabolic dysfunction-associated steatotic liver disease (MASLD). In this 3-month feasibility pi ... Full text Cite

Abstract 16282: Incident Heart Failure With Preserved Ejection Fraction in a Cohort of Patients With Biopsy-Proven Non-Alcoholic Fatty Liver Disease

Conference Circulation · November 7, 2023 Introduction: Non-alcoholic fatty liver disease (NAFLD) is associated with heart failure with preserved ejection fraction (HFpEF), independent of shared risk factors. The aim of this study was to dete ... Full text Cite

1359-P: Gaps in the Use of Evidence-Based Diabetes Medications for NASH

Conference Diabetes · June 20, 2023 Patients with type 2 diabetes (T2D) and nonalcoholic steatohepatitis (NASH) are at exceedingly high risk of NASH progression to cirrhosis and end-stage liver disease. T2D medications shown to improve histologic features of NASH, such as GLP-1 recep ... Full text Cite

Abstract 4117: Utilizing RNA aptamers for biomarker discovery in a novel cell culture system for hepatocellular carcinoma

Conference Cancer Research · October 1, 2014 AbstractIntroduction: Current serum biomarkers for hepatocellular carcinoma (HCC) lack the sensitivity and specificity to be effective screening tools. Aptamers are single-stranded RNA oligonucleotides that ... Full text Cite

Epigenetic Regulation of Gene Expression in NAFLD

Conference GASTROENTEROLOGY · May 1, 2012 Link to item Cite

Factors Influencing Participation in Hepatitis C Research Trials

Conference American Journal of Gastroenterology · September 2007 Full text Cite